Table 1.
Demographics and clinical characteristics of the study population.
| Parameters | |||
|---|---|---|---|
| Number of patients | 152 | ||
| Male gender (n;%) | 57; 37.5% | ||
| Mean age (years ± SD) | 42.79 ± 11.66 | ||
| Illness duration (years ± SD) | 17.89 ± 11.56 | ||
| Number of episodes | 25.19 ± 13.56 | ||
| Smoker (n; %) | 93; 61.18% | ||
| Antipsychotic medication | |||
| Number, % | Mean dose (mg) ± SD | Chlorpromazine equivalent (mg) | |
| Amisulpride (n; %) | 4; 2.63% | 450 ± 100 | 450 |
| Aripiprazole (n; %) | 9; 5.92% | 16.12 ± 7.41 | 214.94 |
| Clozapine (n; %) | 4; 2.63% | 400 ± 70.71 | 400 |
| Olanzapine (n; %) | 70; 46.05% | 14.5 ± 4.43 | 290 |
| Quetiapine (n; %) | 6; 3.94% | 566.66 ± 150.55 | 755.55 |
| Paliperidone (n; %) | 3; 1.97% | 8 ± 1.73 | 400 |
| Risperidone (n; %) | 56; 36.84% | 3.33 ± 1.61 | 333 |